Triumph Science & Technology Co., Ltd. Class A

Triumph Science & Technology Co., Ltd. Class A

SSSE:600552
11.78
CNY
+0.09
(+0.77%)
0.14EPS
124.26P/E
16.06BMarket Cap
Apr 01Next Earn

Total Valuation

CNY

As of September 30, 2026, Triumph Science & Technology Co., Ltd. Class A carries a market capitalization of 16.06B, placing it among publicly traded companies globally. Its enterprise value stands at 20.86B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap16.06B
Enterprise Value20.86B

Important Dates

Triumph Science & Technology Co., Ltd. Class A's next confirmed earnings release is scheduled for April 1, 2027.

Earnings Date4/1/2027

Share Statistics

As of September 30, 2026, Triumph Science & Technology Co., Ltd. Class A has 944.61M shares outstanding.

Shares Outstanding944.61M

Valuation Ratios

As of September 30, 2026, Triumph Science & Technology Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 124.26. The price-to-sales ratio is 2.54, and the price-to-book ratio stands at 3.65.

PE Ratio124.26
PS Ratio2.54
PB Ratio3.65
P/TBV Ratio4.77

Enterprise Valuation

As of September 30, 2026, Triumph Science & Technology Co., Ltd. Class A trades at an EV/EBITDA multiple of 114.28 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.30 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 114.28 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 20.86B versus a market cap of 16.06B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales3.30
EV / EBITDA114.28
EV / EBIT114.28

Financial Position

As of September 30, 2026, Triumph Science & Technology Co., Ltd. Class A maintains a current ratio of 1.16, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 99.08, indicating elevated leverage, while an interest coverage ratio of 1.43 demonstrates limited ability to service its debt obligations.

Current Ratio1.16
Quick Ratio0.09
Debt / Equity99.08
Debt / EBITDA26.46
Interest Coverage1.43

Financial Efficiency

CNY

These figures cover the twelve months ended September 30, 2026. The company generates approximately 967,100.16 in revenue per employee across its workforce of 6,529.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee967,100.16
Employee Count6,529.00

Taxes

CNY

Over the twelve months ended September 30, 2026, Triumph Science & Technology Co., Ltd. Class A recorded 52.20M in income tax expense. That works out to an effective tax rate of 28.35, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 184.17M, leaving 129.18M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax52.20M
Effective Tax Rate28.35

Stock Price Statistics

CNY

As of the close on November 17, 2026, Triumph Science & Technology Co., Ltd. Class A's stock has declined approximately 1.09% over the past 52 weeks. The 50-day moving average sits at 14.91, while the 200-day moving average is 16.57.

52-Week Price Change-1.09%
50-Day Moving Average14.91
200-Day Moving Average16.57

Income Statement

CNY

Over the twelve months ended September 30, 2026, Triumph Science & Technology Co., Ltd. Class A generated 6.31B in revenue and converted that into 129.18M in net income, yielding earnings per share of 0.14. EBITDA reached 182.56M, while operating income came in at 376.54M.

Revenue6.31B
Gross Profit1.17B
Operating Income376.54M
Pretax Income184.17M
Net Income129.18M
EBITDA182.56M
EBIT182.56M
Earnings Per Share (EPS)0.14

Balance Sheet

CNY

As of September 30, 2026, Triumph Science & Technology Co., Ltd. Class A holds 504.46M in cash and equivalents against 4.83B in total debt, resulting in a net debt position of 4.13B. Total book value stands at 4.39B, with working capital of 905.71M providing operational flexibility.

Cash & Cash Equivalents504.46M
Total Debt4.83B
Net Debt4.13B
Equity (Book Value)4.39B
Book Value Per Share4.65
Working Capital905.71M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-302.21M

Margins

Over the twelve months ended September 30, 2026, Triumph Science & Technology Co., Ltd. Class A posted a gross margin of 18.57, reflecting its pricing power and cost economics. The operating margin of 5.96 and net profit margin of 2.05 provide insight into operational efficiency.

Gross Margin18.57
Operating Margin5.96
Pretax Margin2.92
Profit Margin2.05
EBITDA Margin2.89

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Triumph Science & Technology Co., Ltd. Class A paid dividends of 0.21 per share. The dividend payout ratio of 148.37 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 2.72, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Triumph Science & Technology Co., Ltd. Class A shareholders.

Dividend Per Share0.21
Payout Ratio148.37
Shareholder Yield2.72

Stock Splits

Triumph Science & Technology Co., Ltd. Class A's most recent stock split took place on June 16, 2017 with a 1:2 split ratio.

Last Split Date6/16/2017
Split Ratio1:2

Scores

As of September 30, 2026, Triumph Science & Technology Co., Ltd. Class A has an Altman Z-Score of 1.98, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.98